苏州盛迪亚生物医药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
5
NMPA:5
Drug Approvals
Trastuzumab rezetecan for Injection
- Product Name
- 艾维达
- Approval Number
- 国药准字S20250024
- Approval Date
- May 27, 2025
NMPA
Clinical Trials
No trials found
News
No news found